120 related articles for article (PubMed ID: 16820203)
1. Differential release of plasminogen activator inhibitors (PAIs) during dual perfusion of human placenta: implications in preeclampsia.
Guller S; Ma Y; Malek A; Di Santo S; Schneider H
Placenta; 2007 Apr; 28(4):278-85. PubMed ID: 16820203
[TBL] [Abstract][Full Text] [Related]
2. Dual in vitro perfusion of an isolated cotyledon as a model to study the implication of changes in the third trimester placenta on preeclampsia.
Di Santo S; Sager R; Andres AC; Guller S; Schneider H
Placenta; 2007 Apr; 28 Suppl A():S23-32. PubMed ID: 17337301
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of PAI-2 mRNA and protein in pregnancies complicated with intrauterine fetal growth retardation.
Grancha S; Estellés A; Gilabert J; Chirivella M; España F; Aznar J
Thromb Haemost; 1996 Nov; 76(5):761-7. PubMed ID: 8950787
[TBL] [Abstract][Full Text] [Related]
4. Uteroplacental hemostasis in intrauterine fetal growth retardation.
Sheppard BL; Bonnar J
Semin Thromb Hemost; 1999; 25(5):443-6. PubMed ID: 10625199
[TBL] [Abstract][Full Text] [Related]
5. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia.
Estellés A; Gilabert J; Grancha S; Yamamoto K; Thinnes T; España F; Aznar J; Loskutoff DJ
Thromb Haemost; 1998 Mar; 79(3):500-8. PubMed ID: 9580327
[TBL] [Abstract][Full Text] [Related]
6. Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia.
Kanfer A; Bruch JF; Nguyen G; He CJ; Delarue F; Flahault A; Nessmann C; Uzan S
Lab Invest; 1996 Jan; 74(1):253-8. PubMed ID: 8569189
[TBL] [Abstract][Full Text] [Related]
7. Perfusion of the human placenta with red blood cells and xanthine oxidase mimics preeclampsia in-vitro.
Centlow M; Junus K; Nyström H; May K; Larsson I; Olsson MG; Akerström B; Sager R; Schneider H; Hansson SR
Z Geburtshilfe Neonatol; 2009 Jun; 213(3):89-95. PubMed ID: 19536708
[TBL] [Abstract][Full Text] [Related]
8. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia.
Schjetlein R; Abdelnoor M; Haugen G; Husby H; Sandset PM; Wisløff F
Acta Obstet Gynecol Scand; 1999 Mar; 78(3):191-7. PubMed ID: 10078579
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation.
Estellés A; Gilabert J; Keeton M; Eguchi Y; Aznar J; Grancha S; Espña F; Loskutoff DJ; Schleef RR
Blood; 1994 Jul; 84(1):143-50. PubMed ID: 8018914
[TBL] [Abstract][Full Text] [Related]
10. Nox4 mediates the expression of plasminogen activator inhibitor-1 via p38 MAPK pathway in cultured human endothelial cells.
Jaulmes A; Sansilvestri-Morel P; Rolland-Valognes G; Bernhardt F; Gaertner R; Lockhart BP; Cordi A; Wierzbicki M; Rupin A; Verbeuren TJ
Thromb Res; 2009 Sep; 124(4):439-46. PubMed ID: 19540572
[TBL] [Abstract][Full Text] [Related]
11. Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia.
Wikström AK; Nash P; Eriksson UJ; Olovsson MH
Am J Obstet Gynecol; 2009 Dec; 201(6):597.e1-8. PubMed ID: 19683696
[TBL] [Abstract][Full Text] [Related]
12. Vasoactivity to and endogenous release of vascular endothelial growth factor in the in vitro perfused human placental lobule from pregnancies complicated by preeclampsia.
Brownbill P; Mills TA; Soydemir DF; Sibley CP
Placenta; 2008 Nov; 29(11):950-5. PubMed ID: 18845336
[TBL] [Abstract][Full Text] [Related]
13. Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia.
Downing JW; Ramasubramanian R; Johnson RF; Minzter BH; Paschall RL; Sundell HW; Engelhardt B; Lewis R
Med Hypotheses; 2004; 63(6):1057-64. PubMed ID: 15504576
[TBL] [Abstract][Full Text] [Related]
14. Acute and chronic modulation of placental chorionic plate artery reactivity by reactive oxygen species.
Mills TA; Wareing M; Shennan AH; Poston L; Baker PN; Greenwood SL
Free Radic Biol Med; 2009 Jul; 47(2):159-66. PubMed ID: 19389471
[TBL] [Abstract][Full Text] [Related]
15. Protein composition of microparticles shed from human placenta during placental perfusion: Potential role in angiogenesis and fibrinolysis in preeclampsia.
Guller S; Tang Z; Ma YY; Di Santo S; Sager R; Schneider H
Placenta; 2011 Jan; 32(1):63-9. PubMed ID: 21074265
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy.
Coolman M; de Groot CJ; Steegers EA; Geurts-Moespot A; Thomas CM; Steegers-Theunissen RP; Sweep FC
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):22-8. PubMed ID: 16584829
[TBL] [Abstract][Full Text] [Related]
17. High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension.
Florio P; Torricelli M; De Falco G; Leucci E; Giovannelli A; Gazzolo D; Severi FM; Bagnoli F; Leoncini L; Linton EA; Petraglia F
J Hypertens; 2006 Sep; 24(9):1831-40. PubMed ID: 16915033
[TBL] [Abstract][Full Text] [Related]
18. Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies.
Catarino C; Rebelo I; Belo L; Rocha S; Castro EB; Patricio B; Quintanilha A; Santos-Silva A
Thromb Res; 2008; 123(2):219-24. PubMed ID: 18384840
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of N-myc downstream-regulated gene 1 (NDRG1) in placentas from pregnancies complicated by intrauterine growth restriction or preeclampsia.
Choi SJ; Oh SY; Kim JH; Sadovsky Y; Roh CR
Am J Obstet Gynecol; 2007 Jan; 196(1):45.e1-7. PubMed ID: 17240229
[TBL] [Abstract][Full Text] [Related]
20. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls.
Farina A; Sekizawa A; Purwosunu Y; Rizzo N; Banzola I; Concu M; Morano D; Giommi F; Bevini M; Mabrook M; Carinci P; Okai T
Prenat Diagn; 2006 Dec; 26(12):1115-20. PubMed ID: 16952198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
